Drug Information

Drug General Information
Drug ID
D0RF6M
Former ID
DIB020364
Drug Name
ML-18
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533098]
Structure
Download
2D MOL

3D MOL
Formula
C32H35N5O5
InChI
InChI=1S/C32H35N5O5/c1-42-26-15-9-23(10-16-26)32(17-5-2-6-18-32)21-34-30(38)29(19-22-20-33-28-8-4-3-7-27(22)28)36-31(39)35-24-11-13-25(14-12-24)37(40)41/h3-4,7-16,20,29,33H,2,5-6,17-19,21H2,1H3,(H,34,38)(H2,35,36,39)/t29-/m0/s1
InChIKey
JOKVJNCYOSFDGC-LJAQVGFWSA-N
PubChem Compound ID
91827363
Target and Pathway
Target(s) Bombesin receptor Target Info Antagonist [533098]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (q) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
References
Ref 533098ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth. Peptides. 2015 Feb;64:55-61.
Ref 533098ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth. Peptides. 2015 Feb;64:55-61.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.